Comprassion the Lipid Profile among Children Suffreing from Nephrotic Syndrome before and after Remission

Aims: The study aimed to investigate serum cholesterol, triglycerides, LDL (low density lipoprotein), VLDL (very low-density lipoprotein), and HDL (high density lipoprotein) levels in nephrotic syndrome at the onset and during remission in first episode and relapse cases, as well as the relationship between dyslipidemia persistence and severity and disease duration and relapse frequency. Materials and Methods: A hospital-based prospective study including 30 children aged 0 to 12 years with nephrotic syndrome. They were steroid responsive in 22 cases and steroid dependent in 8 cases. They were assessed clinically and a lipid profile was taken at the start, during remission, and after treatment. A total of 30 children without liver or kidney disease were included as controls. Results: The mean blood cholesterol, triglycerides, LDL, and VLDL all increased significantly (p0.005). When compared to controls, HDL levels increased dramatically (P value 0.001) after nephrotic syndrome treatment. Lipid levels (serum cholesterol, triglycerides, LDL, VLDL) were significantly lower during remission in first-episode nephrotic syndrome cases, whereas lipid levels were significantly greater even during remission in recurrent cases. After treatment, total cholesterol and TGL levels were found to be higher, with P values of 0.004 and 0.004 respectively, as the duration of disease increased. Conclusion: The current investigation demonstrates that widespread hyperlipidemia is present in nephrotic syndrome. When compared to recently diagnosed with NS, this was much higher in relapse cases. Lipid profiles return to normal during remission recently diagnosed with NS, but they are considerably higher in recurrence instances, even during remission. As a result, there is a justification for treatment.